Cargando…

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

Response to treatment with selective serotonin reuptake inhibitors (SSRIs) varies considerably between patients. The International SSRI Pharmacogenomics Consortium (ISPC) was formed with the primary goal of identifying genetic variation that may contribute to response to SSRI treatment of major depr...

Descripción completa

Detalles Bibliográficos
Autores principales: Biernacka, J M, Sangkuhl, K, Jenkins, G, Whaley, R M, Barman, P, Batzler, A, Altman, R B, Arolt, V, Brockmöller, J, Chen, C H, Domschke, K, Hall-Flavin, D K, Hong, C J, Illi, A, Ji, Y, Kampman, O, Kinoshita, T, Leinonen, E, Liou, Y J, Mushiroda, T, Nonen, S, Skime, M K, Wang, L, Baune, B T, Kato, M, Liu, Y L, Praphanphoj, V, Stingl, J C, Tsai, S J, Kubo, M, Klein, T E, Weinshilboum, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462610/
https://www.ncbi.nlm.nih.gov/pubmed/25897834
http://dx.doi.org/10.1038/tp.2015.47
_version_ 1782375691182931968
author Biernacka, J M
Sangkuhl, K
Jenkins, G
Whaley, R M
Barman, P
Batzler, A
Altman, R B
Arolt, V
Brockmöller, J
Chen, C H
Domschke, K
Hall-Flavin, D K
Hong, C J
Illi, A
Ji, Y
Kampman, O
Kinoshita, T
Leinonen, E
Liou, Y J
Mushiroda, T
Nonen, S
Skime, M K
Wang, L
Baune, B T
Kato, M
Liu, Y L
Praphanphoj, V
Stingl, J C
Tsai, S J
Kubo, M
Klein, T E
Weinshilboum, R
author_facet Biernacka, J M
Sangkuhl, K
Jenkins, G
Whaley, R M
Barman, P
Batzler, A
Altman, R B
Arolt, V
Brockmöller, J
Chen, C H
Domschke, K
Hall-Flavin, D K
Hong, C J
Illi, A
Ji, Y
Kampman, O
Kinoshita, T
Leinonen, E
Liou, Y J
Mushiroda, T
Nonen, S
Skime, M K
Wang, L
Baune, B T
Kato, M
Liu, Y L
Praphanphoj, V
Stingl, J C
Tsai, S J
Kubo, M
Klein, T E
Weinshilboum, R
author_sort Biernacka, J M
collection PubMed
description Response to treatment with selective serotonin reuptake inhibitors (SSRIs) varies considerably between patients. The International SSRI Pharmacogenomics Consortium (ISPC) was formed with the primary goal of identifying genetic variation that may contribute to response to SSRI treatment of major depressive disorder. A genome-wide association study of 4-week treatment outcomes, measured using the 17-item Hamilton Rating Scale for Depression (HRSD-17), was performed using data from 865 subjects from seven sites. The primary outcomes were percent change in HRSD-17 score and response, defined as at least 50% reduction in HRSD-17. Data from two prior studies, the Pharmacogenomics Research Network Antidepressant Medication Pharmacogenomics Study (PGRN-AMPS) and the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, were used for replication, and a meta-analysis of the three studies was performed (N=2394). Although many top association signals in the ISPC analysis map to interesting candidate genes, none were significant at the genome-wide level and the associations were not replicated using PGRN-AMPS and STAR*D data. Top association results in the meta-analysis of response included single-nucleotide polymorphisms (SNPs) in the HPRTP4 (hypoxanthine phosphoribosyltransferase pseudogene 4)/VSTM5 (V-set and transmembrane domain containing 5) region, which approached genome-wide significance (P=5.03E−08) and SNPs 5' upstream of the neuregulin-1 gene, NRG1 (P=1.20E−06). NRG1 is involved in many aspects of brain development, including neuronal maturation and variations in this gene have been shown to be associated with increased risk for mental disorders, particularly schizophrenia. Replication and functional studies of these findings are warranted.
format Online
Article
Text
id pubmed-4462610
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-44626102015-06-11 The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response Biernacka, J M Sangkuhl, K Jenkins, G Whaley, R M Barman, P Batzler, A Altman, R B Arolt, V Brockmöller, J Chen, C H Domschke, K Hall-Flavin, D K Hong, C J Illi, A Ji, Y Kampman, O Kinoshita, T Leinonen, E Liou, Y J Mushiroda, T Nonen, S Skime, M K Wang, L Baune, B T Kato, M Liu, Y L Praphanphoj, V Stingl, J C Tsai, S J Kubo, M Klein, T E Weinshilboum, R Transl Psychiatry Original Article Response to treatment with selective serotonin reuptake inhibitors (SSRIs) varies considerably between patients. The International SSRI Pharmacogenomics Consortium (ISPC) was formed with the primary goal of identifying genetic variation that may contribute to response to SSRI treatment of major depressive disorder. A genome-wide association study of 4-week treatment outcomes, measured using the 17-item Hamilton Rating Scale for Depression (HRSD-17), was performed using data from 865 subjects from seven sites. The primary outcomes were percent change in HRSD-17 score and response, defined as at least 50% reduction in HRSD-17. Data from two prior studies, the Pharmacogenomics Research Network Antidepressant Medication Pharmacogenomics Study (PGRN-AMPS) and the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, were used for replication, and a meta-analysis of the three studies was performed (N=2394). Although many top association signals in the ISPC analysis map to interesting candidate genes, none were significant at the genome-wide level and the associations were not replicated using PGRN-AMPS and STAR*D data. Top association results in the meta-analysis of response included single-nucleotide polymorphisms (SNPs) in the HPRTP4 (hypoxanthine phosphoribosyltransferase pseudogene 4)/VSTM5 (V-set and transmembrane domain containing 5) region, which approached genome-wide significance (P=5.03E−08) and SNPs 5' upstream of the neuregulin-1 gene, NRG1 (P=1.20E−06). NRG1 is involved in many aspects of brain development, including neuronal maturation and variations in this gene have been shown to be associated with increased risk for mental disorders, particularly schizophrenia. Replication and functional studies of these findings are warranted. Nature Publishing Group 2015-04 2015-04-21 /pmc/articles/PMC4462610/ /pubmed/25897834 http://dx.doi.org/10.1038/tp.2015.47 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Original Article
Biernacka, J M
Sangkuhl, K
Jenkins, G
Whaley, R M
Barman, P
Batzler, A
Altman, R B
Arolt, V
Brockmöller, J
Chen, C H
Domschke, K
Hall-Flavin, D K
Hong, C J
Illi, A
Ji, Y
Kampman, O
Kinoshita, T
Leinonen, E
Liou, Y J
Mushiroda, T
Nonen, S
Skime, M K
Wang, L
Baune, B T
Kato, M
Liu, Y L
Praphanphoj, V
Stingl, J C
Tsai, S J
Kubo, M
Klein, T E
Weinshilboum, R
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
title The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
title_full The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
title_fullStr The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
title_full_unstemmed The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
title_short The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
title_sort international ssri pharmacogenomics consortium (ispc): a genome-wide association study of antidepressant treatment response
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462610/
https://www.ncbi.nlm.nih.gov/pubmed/25897834
http://dx.doi.org/10.1038/tp.2015.47
work_keys_str_mv AT biernackajm theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT sangkuhlk theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT jenkinsg theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT whaleyrm theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT barmanp theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT batzlera theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT altmanrb theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT aroltv theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT brockmollerj theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT chench theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT domschkek theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT hallflavindk theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT hongcj theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT illia theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT jiy theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT kampmano theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT kinoshitat theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT leinonene theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT liouyj theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT mushirodat theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT nonens theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT skimemk theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT wangl theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT baunebt theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT katom theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT liuyl theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT praphanphojv theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT stingljc theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT tsaisj theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT kubom theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT kleinte theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT weinshilboumr theinternationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT biernackajm internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT sangkuhlk internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT jenkinsg internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT whaleyrm internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT barmanp internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT batzlera internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT altmanrb internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT aroltv internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT brockmollerj internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT chench internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT domschkek internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT hallflavindk internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT hongcj internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT illia internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT jiy internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT kampmano internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT kinoshitat internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT leinonene internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT liouyj internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT mushirodat internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT nonens internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT skimemk internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT wangl internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT baunebt internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT katom internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT liuyl internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT praphanphojv internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT stingljc internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT tsaisj internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT kubom internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT kleinte internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse
AT weinshilboumr internationalssripharmacogenomicsconsortiumispcagenomewideassociationstudyofantidepressanttreatmentresponse